Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Annals of Surgical Oncology

Volumn 15, Issue 1, 2008, Pages 268-273

  Dominguez, Francisco J ^a   Golshan, Mehra ^b   Black, Dalliah M ^a   Hughes, Kevin S ^a   Gadd, Michele A ^a   Christian, Roger ^b   Lesnikoski, Beth Ann ^b   Specht, Michelle ^a   Michaelson, James ^a   Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast neoplasm; Carcinoma intraductal; Mastectomy; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST; CARCINOMA IN SITU; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MICROMETASTASIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38049161552     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9610-6     Document Type: Article

References (28)

1. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001;8:275-7
2. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20
3. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-42
4. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309-13
5. Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Paganelli G, Viale G. Sentinel lymph node biopsy for localized ductal carcinoma in situ? Breast 2005;14:520-2
6. Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005;190:563-6
7. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542-51
8. Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg 2006;192:455-7
9. Sakr R, Barranger E, Antoine M, Prugnolle H. Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol 2006;94:426-30
10. Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005;5:28-33
11. Leidenius M, Salmenkivi K, Von Smitten K, Heikkila P. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 2006;94:380-4
12. Guiliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401
13. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7
14. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;339:941-6
15. Tan JC, McCready DR, Easson AM, Leong WL Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol 2007;14:638-45
16. Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000;180:274-7
17. Sabel MS, Degnim A, Wilkins EG, Diehl KM, Cimmino VM, Chang AE, Newman LA. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg 2004;187:673-8
18. Langer S, Guenther JM, Haigh PI, Difronzo. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004;70:881-5
19. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging handbook-TNM classification of malignant tumors, 6th ed. New York: Springer Verlag, 2002
20. Singletary SE, Greene FL, Sobin LH, (eds). Classification of isolated rumor cells. Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003;12:2704-41
21. Gadd M, Harris J, Taghian A, Powell S, O'Neill A, Kaelin C, Lesniloski B, Rhei E, Younger J, Winer E, Smith B. Prospective study of axillary radiation without axillary dissection for breast cancer patients with a positive sentinel node. San Antonio Breast Cancer Symposium, San Antonio, Texas, 2005. Avalaible: http://www.abstracts2view.com/ sabcs05/view.php?nu = SABCS05L_10190
22. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Onc 2007;14:1890-5
23. Bleiweiss IJ, Nagi SC, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 2006;24:2013-8
24. Lara J, Young S, Velilla R, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ. Cancer 2003;98:2105-13
25. El-Tamer M, Chun J, Gill M, Bassi D, Lee S, Hibshoosh H, Mansukhani M. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann Surg Oncol 2005;12:254-9
26. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368-70
27. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-14
28. Hoorntje LE, Schipper MEI, Peeters PHM, Bellot F, Storm RK, Borel Rinkes IHM. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10:748-53